The Pathogen and Microbiome Institute has grown tremendously in the past decade and a half. PMI now occupies two floors in the Applied Research and Development Building. We have doubled the number of Undergraduate Students and currently have approximately 47 Undergraduate Students, bringing the total number of PMI employees to a whopping 142 total.
The PMI Admin Team supports all research teams at PMI in placing orders, assisting with travel, receiving packages, & onboarding and offboarding employees.
Dr. Walker is presenting at a conference in Phoenix at the ARBC-Flinn Research Conference on her rabies research.
Dr. Dave Wagner discusses Burkholderia thailandensis on the CDC’s podcast in the EIM Series.
Dr. Walker is presenting at a conference in Canada regarding her bat bridge research.
Nate Stone shares his research on Leptospira bacteria and a new novel method for conducting the research.
Emma is an undergraduate research assistant majoring in Biomedical Science and minoring in Psychology. Her research has focused on using genetics to monitor a threatened snake species and applying a new non-invasive method to identify rabies virus.
Looking back at 2022, we count the top 10 research highlights with the Walker Lab Team..
Paul Keim shares a greeting to the new semester and details some of the fun and exciting things planned.
Paul Keim’s career as a pathogen expert is featured in an interview by the Flinn Foundation. The founder of PMI details his illustrious early career as a geneticist, to his recent participation in The Anthrax Attacks documentary on Netflix.
Recently, Drs. Bridget Barker, Erik Settles, and Paul Keim were awarded a large NIH grant to develop a vaccine to prevent the disease. This is a 5-year project with many problems to solve before the vaccine is ready.
Magda joined the Species from Feces team to save the world one poo pile at a time. It’s hard to believe how much information is in scat.
With Omicron Variant infections on the rise, the best way to protect yourself and your community is to mask up and get the shot.
Known for the infamous Black Death, plague continues to affect hundreds of people globally each year in underdeveloped countries. An antimicrobial resistant (AMR) strain of Yersinia pestis was discovered from a 2013 Madagascar pneumonic plague outbreak. Newly published research from Dave Wagner and colleagues, reveals for the first time that AMR Y. pestis can be […]
Wagner is a disease ecologist whose primary research interests are the ecology and evolution of infectious diseases. He uses genetic and genomic variation within pathogen, vector and host species.
The COVID-19 Testing Service Center (CTSC) was establish to perform in vitro testing of Coronavirus. Test results show that Stenoparib, an ovarian cancer drug already approved by the FDA, is effective in combating coronavirus. When used in combination with Remdesivir, the drugs work in tandem to successfully inhibit viral multiplication. The results are published […]
Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerase (PARP), blocks replication of the SARS-CoV-2 and HCoV-NL63 human coronaviruses in vitro.
We are specialized in developing in vitro assay models for CoV-2 and other high-risk pathogens using our unique biosafety / biosecurity facilities.
PMI has recruited world class scientists in genomics, infectious disease, computational analysis, bioinformatics, and microbiome research.